AUDIO From Medialink and Pfizer: Recent Research Shows Benefit for Women With Early Breast Cancer Who Switch Hormonal Therapies
Posted on: Thursday, 10 May 2007, 21:00 CDT
NEW YORK, May 10 /PRNewswire/ -- Breast cancer is the second leading cause of cancer death in women. An international study shows that switching from the hormonal therapy tamoxifen to a newer breast cancer drug may improve outcomes for postmenopausal women living with this deadly disease.
Listen to this report from Pfizer at: http://media.medialink.com/WebNR.aspx?story=33421
Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://media.medialink.com/.
05CH07-0103
Audio: http://media.medialink.com/WebNR.aspx?story=33421
Medialink and Pfizer
CONTACT: Medialink New York, +1-888-560-5578 or mediadesk@medialink.com
Web site: http://media.medialink.com/WebNR.aspx?story=33421http://media.medialink.com/
Source: PRNewswire
Related Articles
- American Association for Homecare Sets the Record Straight About Recent Home Medical Equipment Issues in the News
- BMJ Award for NHS Choices Guide to the Medical Science in the News
- Journalists Find Relief From Spam With Woomail
- AUDIO From Medialink and Doritos: Doritos and MTV Casting Call for New Reality Dating Series
- Osteopathic Physician Identified in Paris Hilton Case is a Real Doctor
- Community Oncology Alliance Refutes NBC Nightly News Story 'Cancer Docs Profit From Chemotherapy Drugs'
- AUDIO From Medialink: Preventing Cervical Cancer
- VIDEO From Medialink: Scientists Have Launched a Clinical Trial That Could Ultimately Allow Doctors to Tailor Treatment for Cancer Patients
- Lutheran to Break Ground on Cancer Center
- Heart Disease Overtakes Cancer As Number One Killer of Women in U.S.; Nearly Half of Female Heart Attack Victims Will Die
 |
 |
User Comments (0)
RSS Feeds